• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Newron Pharmaceuticals SpA

+ Add to Watchlist

NWRN:SW

13.40 CHF 0.40 3.08%

As of 11:43:48 ET on 04/17/2014.

Snapshot for Newron Pharmaceuticals SpA (NWRN)

Open: 13.00 Day's Range: 12.70 - 13.45 Volume: 42,555
Previous Close: 13.00 52wk Range: 7.91 - 19.50 1-Yr Rtn: +65.84%

Stock Chart for NWRN

No chart data available.
  • NWRN:SW 13.40
  • 1D
  • 1M
  • 1Y
13.00
Interactive NWRN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NWRN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 19.1013
Relative P/E vs. SMI -
Earnings Per Share (EUR) (ttm) -0.6170
Est. EPS (EUR) (12/2014) 0.5750
Est. PEG Ratio -
Market Cap (M CHF) 152.57
Shares Outstanding (M) 11.39
30 Day Average Volume 34,415
Price/Book (mrq) 4.9093
Price/Sale (ttm) 35.6471
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/16/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NWRN

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for NWRN

Newron Pharmaceuticals SpA is a research and development biopharmaceutical company. The Company focuses on and develops therapies for the Central Nervous System (CNS) in cases such as Parkinson's disease, neuropathic low back pain and other cognitive disorders.

Stefan WeberCEO/CFOMarco CaremiExec VP:Business Development
Ravi AnandChief Medical OfficerRoberto GalliVP:Finance
More Company Profile & Key Executives for NWRN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil